Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | XIAP | P98170 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | IKBKB | O14920 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | PTPRA | P18433 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 3/20 | 0.33 |
| ▸ | SLC1A5 | Q15758 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | AGER | Q15109 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL626679 | 1.00 | ALPI (0.35) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL626680 | 1.00 | ALPI (0.35) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Water SCHEMBL15012752 | 0.98 | ALPI (0.34) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Water SCHEMBL15012669 | 0.98 | ALPI (0.34) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Water SCHEMBL15012398 | 0.98 | ALPI (0.34) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL2836743 | 0.87 | ALPI (0.41) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL2704117 | 0.87 | FFAR1 (0.43) | IKBKBKMT2APOLBTSHRFFAR1 | |
| SCHEMBL15012267 | 0.82 | LTA4H (0.45) | IKBKBKMT2AMTNR1AMTNR1BLTA4H | |
| SCHEMBL15012266 | 0.82 | LTA4H (0.45) | IKBKBKMT2AMTNR1AMTNR1BLTA4H | |
| SCHEMBL15012672 | 0.82 | LTA4H (0.45) | IKBKBKMT2AMTNR1AMTNR1BLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3164131-B1 | 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS | SANOFI SA (FR) | 2018-08-22 | — | — | EP | claimed |
| US-9968605-B2 | 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis | SANOFI (FR) | 2018-05-15 | — | — | US | claimed |
| EP-3184095-A1 | ADMINISTRATION UNITS COMPRISING POLYMORPH 1 OF 2-(2-METHYLAMINO-PYRIMIDIN-4-YL]-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE | IP Gesellschaft für Management mbH (DE) | 2017-06-28 | — | — | EP | claimed |
| EP-3164131-A1 | 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS | Sanofi (FR) | 2017-05-10 | — | — | EP | claimed |
| US-20170119765-A1 | 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-IH-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS | SANOFI (FR) | 2017-05-04 | — | — | US | claimed |
| EP-2787998-B1 | CRYSTALLINE FORMS OF 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE | SANOFI SA (FR) | 2016-11-09 | — | — | EP | claimed |
| WO-2016001197-A1 | 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS | SANOFI (FR) | 2016-01-07 | — | — | WO | claimed |
| US-9067918-B2 | Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide | SANOFI (FR) | 2015-06-30 | — | — | US | claimed |
| US-20140336211-A1 | Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-Indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino) -ethyl ] -amide | SANOFI (FR) | 2014-11-13 | — | — | US | claimed |
| US-8877926-B2 | Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives | SANOFI (FR) | 2014-11-04 | — | — | US | claimed |
| EP-2787998-A1 | CRYSTALLINE FORMS OF 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE | SANOFI (FR) | 2014-10-15 | — | — | EP | claimed |
| EP-2603491-B1 | PROCESS FOR THE PREPARATION OF ENANTIOMERIC FORMS OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI SA (FR) | 2014-09-24 | — | — | EP | claimed |
| US-20130211085-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERIC FORMS OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI (FR) | 2013-08-15 | — | — | US | claimed |
| EP-2603491-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERIC FORMS OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI (FR) | 2013-06-19 | — | — | EP | claimed |
| WO-2013083553-A1 | CRYSTALLINE FORMS OF 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE | SANOFI (FR) | 2013-06-13 | — | — | WO | claimed |
| WO-2012019967-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERIC FORMS OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI (FR) | 2012-02-16 | — | — | WO | claimed |
| EP-3164131-B1 | 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS | SANOFI SA (FR) | 2018-08-22 | — | — | EP | disclosed |
| US-9968605-B2 | 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis | SANOFI (FR) | 2018-05-15 | — | — | US | disclosed |
| WO-2012019967-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERIC FORMS OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI (FR) | 2012-02-16 | — | — | WO | disclosed |
| WO-2012019967-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERIC FORMS OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | SANOFI (FR) | 2012-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130211085-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERIC FORMS OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES | C9, DDT, IDUA | ALPI 3968/4885PKM 2991/4885PTGS1 4140/4885 |
| US-20140336211-A1 | Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-Indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino) -ethyl ] -amide | IDO1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, IDO2 | ALPI 984/4885PKM 2383/4885PTGS1 2393/4885 |
| US-20170119765-A1 | 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-IH-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS | IDO1, IDO2, NAT1 | ALPI 848/4885PKM 2207/4885PTGS1 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.